Error: Could not add to watchlist. X

Agios Pharmaceuticals Inc

+ Watchlist
AGIO:US
NASDAQ GS
123.70
USD
1.48
1.21%
As of 20:10:00 ET on 06/02/2015.
Open
122.04
Day Range
120.02 - 126.35
Volume
404,662
Previous Close
122.22
52Wk Range
32.66 - 138.85
1 Yr Return
236.51%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.33
Market Cap (b USD)
4.614
Shares Outstanding (m)
37.298
Price/Sales (TTM)
48.15
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
There are currently no news stories for this ticker. Please check back later.
Profile
Agios Pharmaceuticals, Inc. discovers and develops therapeutics in the field of cancer metabolism. The Company develops drugs focusing on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals operates in the United States.
ADDRESS
38 Sidney Street
Cambridge, MA 02139-4169
United States
PHONE
1-617-649-8600
  • David P Schenkein
    Chief Executive Officer
  • J Duncan Higgons
    Chief Operating Officer
  • Chris Bowden
    Chief Medical Officer
  • Scott Biller
    Chief Scientific Officer
  • Glenn Goddard
    Senior VP:Finance
Show More